文献速递心外重症与机械循环支持

机械循环支持期间细胞因子与B细胞表型的时间表达

Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-04-04

本研究前瞻性随访20例植入Heartmate II的成人患者,术前及术后3周检测抗HLA抗体、细胞因子和B细胞免疫表型。结果显示装置植入伴随炎症细胞因子升高和B细胞表型成熟,但无患者出现新发HLA抗体,部分术前已致敏者抗体水平升高,提示炎症和已致敏B细胞成熟可能参与同种致敏机制。

要点

  • MCS植入后出现早期(IL-6、IL-8、IL-10)和晚期(IL-3、IL-4、FGF2、CD40L)细胞因子峰值。
  • 随访期间转换记忆、过渡型和浆母细胞B细胞随时间上调。
  • 无患者出现新发HLA抗体,部分术前已致敏者抗体水平升高。

核心结论

  • MCS装置植入与炎症细胞因子增加和B细胞表型成熟相关。
  • 无患者出现新发HLA抗体,但部分术前已致敏者抗HLA抗体水平升高。
  • 炎症和已致敏B细胞成熟可能参与MCS中同种致敏的发病机制。

研究设计与样本

  • 前瞻性随访研究,纳入2012年9月至2015年3月在本中心接受Heartmate II植入的成人患者。
  • 共分析20例接受Heartmate II的患者。
  • 术前及术后3周采血检测抗HLA抗体、细胞因子表达和B细胞免疫表型。
  • 使用热图展示细胞因子和B细胞亚群的中位数水平时间过程,混合模型分析时间与患者因素的变化。

主要发现

  • 4例患者在随访期间可检测到抗HLA抗体,其中3例术前已有抗体证据。
  • 细胞因子呈现早期峰值(IL-6、IL-8、IL-10)和晚期峰值(IL-3、IL-4、FGF2、CD40L)模式。
  • 转换记忆B细胞、过渡型B细胞和浆母细胞随时间上调。
  • 使用右心室辅助装置和低INTERMACS评分与成熟初始B细胞减少和抗体分泌细胞增加相关。

临床怎么用

  • MCS患者围术期应关注炎症细胞因子和B细胞表型变化,尤其术前已致敏者。
  • 术前已致敏患者术后可能抗体水平升高,需监测抗HLA抗体。

局限性

  • 样本量较小(20例),随访时间较短(术后3周)。
  • 单中心研究,仅纳入Heartmate II患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Allosensitization during mechanical circulatory support (MCS) is a well-described phenomenon, although its mechanism remains unknown. Although immune-mediated interactions from devices or blood transfusions have been proposed, the role of inflammation in this development is less clear. This study was undertaken to further investigate the temporal association of cytokines and B-cell phenotypes in the MCS population. METHODS: Adult patients who received the Heartmate II (Thoratec, Pleasanton, Calif) at our center between September 2012 and March 2015 were prospectively followed after device implantation. Blood draws for anti-human leukocyte antigen (HLA) antibody, cytokine expression, and B-cell immunophenotyping were performed before implantation and for 3 weeks postoperatively. Time courses for cytokines and B-cell subsets were expressed using visual representations of median levels as heat maps, and mixed modeling analysis was used to model changes with time and patient factors. RESULTS: Twenty patients who received the Heartmate II (Thoratec) were analyzed during the study period. Four patients showed measureable levels of anti-HLA antibody during the follow-up period, although 3 of these had evidence of antibodies preoperatively. Analysis of cytokine trends revealed early (interleukin [IL]-6, IL-8, and IL-10) and late peaking (IL-3, IL-4, fibroblast growth factor 2, and CD40L) patterns. Upregulation of switched memory, transitional, and plasma blast B cells occurred over time. Right ventricular assist device use and low Interagency Registry for Mechanically Assisted Circulatory Support score were associated with decreased mature naive and increased antibody-secreting cells. CONCLUSIONS: MCS device implantation was associated with increased inflammatory cytokines and maturation of B-cell phenotypes. No patients developed de novo HLA antibodies, whereas several showed increases in anti-HLA antibody levels detected before implantation. This suggests that inflammation and maturation of existing sensitized B cells might play an important role in the pathogenesis of allosensitization in MCS.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Iyengar A, Wisniewski N, Kwon OJ, et al. Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support. J Thorac Cardiovasc Surg. 2019. PMID: 31056358. doi:10.1016/j.jtcvs.2019.03.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。